Frances Richards is the Director of Oncology Translational Medicine Biomarker Operations at AstraZeneca, a role they assumed in 2022 after leading the Oncology Translational Medicine Operations Group from 2020 to 2022. They have extensive experience in drug discovery and development across oncology, neurology, and ophthalmology, combining expertise from both the pharmaceutical industry and academia. Previously, Frances served as a Principal Associate at Summit plc and held senior academic positions at the University of Birmingham and the University of Cambridge, where they focused on cancer research and molecular genetics. Frances earned a PhD in Cancer Cell Biology from Aston University between 1984 and 1987.
This person is not in the org chart
This person is not in any teams
This person is not in any offices